These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17389201)

  • 41. The potential oncogenic effect of tamoxifen on the endometrium.
    Berlière M; Galant C; Donnez J
    Hum Reprod; 1999 May; 14(5):1381-3. PubMed ID: 10325299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual breast cancers followed by endometrial cancer.
    Dimitrievich E; Sterzinger A
    S D J Med; 2002 Jun; 55(6):227-9. PubMed ID: 12082808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levonorgestrel-releasing intrauterine devices.
    Cohen I
    Lancet; 2001 Mar; 357(9258):801. PubMed ID: 11253990
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of tamoxifen on cervicovaginal smears from patients with breast cancer.
    Abadi MA; Barakat RR; Saigo PE
    Acta Cytol; 2000; 44(2):141-6. PubMed ID: 10740597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An unusual case of a borderline Brenner tumor associated with bilateral serous cystadenoma and endometrial carcinoma.
    Cruz-Galarza D; Pérez-Rodríguez O; Laboy-Torres J; Gutiérrez-Rivera S
    Bol Asoc Med P R; 2014; 106(1):54-6. PubMed ID: 24791367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular genetic characterization of tamoxifen-associated endometrial cancer.
    Prasad M; Wang H; Douglas W; Barakat RR; Ellenson LH
    Gynecol Oncol; 2005 Jan; 96(1):25-31. PubMed ID: 15589576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer.
    Timmerman D; Deprest J; Verbesselt R; Moerman P; De Brabanter J; Vergote I
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S40-2. PubMed ID: 11056312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gynaecological aspects of tamoxifen treatment in breast cancer patients.
    Obwegeser R; Auerbach L; Kubista E
    Cancer Treat Rev; 1997; 23(5-6):289-304. PubMed ID: 9465881
    [No Abstract]   [Full Text] [Related]  

  • 49. Should tamoxifen users be screened for endometrial lesions?
    Neven P; Vergote I
    Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
    [No Abstract]   [Full Text] [Related]  

  • 50. Tamoxifen and risk of endometrial cancer.
    Marsh F; Mayfield M
    Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197382
    [No Abstract]   [Full Text] [Related]  

  • 51. Tamoxifen and risk of endometrial cancer.
    Kairies P
    Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197381
    [No Abstract]   [Full Text] [Related]  

  • 52. Tamoxifen and risk of endometrial cancer.
    Lasset C; Bonadona V; Mignotte H; Brémond A
    Lancet; 2001 Jan; 357(9249):66-7. PubMed ID: 11197379
    [No Abstract]   [Full Text] [Related]  

  • 53. Tamoxifen and risk of endometrial cancer.
    Atkins CD
    Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197378
    [No Abstract]   [Full Text] [Related]  

  • 54. Tamoxifen and risk of endometrial cancer.
    Tempfer C; Kubista E
    Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197377
    [No Abstract]   [Full Text] [Related]  

  • 55. Tamoxifen and risk of endometrial cancer.
    Narod SA; Pal T; Graham T; Mitchell M; Fyles A
    Lancet; 2001 Jan; 357(9249):65-6; author reply 67. PubMed ID: 11197376
    [No Abstract]   [Full Text] [Related]  

  • 56. Controversies regarding tamoxifen and uterine carcinoma.
    Neven P; Vergote I
    Curr Opin Obstet Gynecol; 1998 Feb; 10(1):9-14. PubMed ID: 9484623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report.
    Okugawa K; Hirakawa T; Ogawa S; Kaku T; Nakano H
    Gynecol Oncol; 2002 Nov; 87(2):231-4. PubMed ID: 12477460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy.
    McCluggage WG; Bryson C; Lamki H; Boyle DD
    Int J Gynecol Pathol; 2000 Jul; 19(3):276-9. PubMed ID: 10907178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultrasound, tamoxifen and endometrial carcinoma.
    Ghirardini G; Bianchini A; Rossi GP
    Ultrasound Obstet Gynecol; 1999 May; 13(5):375-6. PubMed ID: 10380310
    [No Abstract]   [Full Text] [Related]  

  • 60. Tamoxifen and the uterus and endometrium.
    Stewart HJ; Knight GM
    Lancet; 1989 Feb; 1(8634):375-6. PubMed ID: 18446929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.